Roche Bolsters Pipeline with Poseida and Kiniksa Deals

By Lucy Haggerty

Pharma Deals Review: Vol 2022 Issue 8 (Table of Contents)

Published: 8 Aug-2022

DOI: 10.3833/pdr.v2022.i8.2713     ISSN: 1756-7874

Section: Research & Development



Starting August with a bang, Roche has entered into two deals with Poseida Therapeutics and Kiniksa Pharmaceuticals to bolster its oncology and inflammatory disease pipelines...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details